000 | 01700 a2200481 4500 | ||
---|---|---|---|
005 | 20250517150243.0 | ||
264 | 0 | _c20190204 | |
008 | 201902s 0 0 eng d | ||
022 | _a1875-6212 | ||
024 | 7 |
_a10.2174/1570161115666170404122535 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKaymaz, Cihangir | |
245 | 0 | 0 |
_aUltrasound-Assisted Catheter-Directed Thrombolysis in High-Risk and Intermediate-High-Risk Pulmonary Embolism: A Meta-Analysis. _h[electronic resource] |
260 |
_bCurrent vascular pharmacology _c01 2018 |
||
300 |
_a179-189 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Meta-Analysis; Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aArterial Pressure _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
650 | 0 | 4 |
_aHemorrhage _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPulmonary Artery _xdiagnostic imaging |
650 | 0 | 4 |
_aPulmonary Embolism _xdiagnostic imaging |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aThrombolytic Therapy _xadverse effects |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUltrasonography, Interventional _xadverse effects |
700 | 1 | _aAkbal, Ozgur Yasar | |
700 | 1 | _aTanboga, Ibrahim Halil | |
700 | 1 | _aHakgor, Aykun | |
700 | 1 | _aYilmaz, Fatih | |
700 | 1 | _aOzturk, Selcuk | |
700 | 1 | _aPoci, Nertila | |
700 | 1 | _aTurkday, Sevim | |
700 | 1 | _aOzdemir, Nihal | |
700 | 1 | _aKonstantinides, Stavros | |
773 | 0 |
_tCurrent vascular pharmacology _gvol. 16 _gno. 2 _gp. 179-189 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1570161115666170404122535 _zAvailable from publisher's website |
999 |
_c27065613 _d27065613 |